Chlorophyllin intervention reduces aflatoxin–DNA adducts in individuals at high risk for liver cancer
Patricia A. Egner(Johns Hopkins University), Thomas W. Kensler(Johns Hopkins University), John D. Groopman(Johns Hopkins University), Yan Wu(Qidong Liver Cancer Prevention Research), Geng-Sun Qian(Shanghai Cancer Institute), Kathy J. Helzlsouer(Mercy Medical Center), Shuang-Yuan Kuang(Shanghai Cancer Institute), Qi-Nan Zhang(Qidong Liver Cancer Prevention Research), Jin-Bing Wang(Qidong Liver Cancer Prevention Research), Yuan-Rong Zhu(Qidong Liver Cancer Prevention Research), Bao-Chu Zhang(Qidong Liver Cancer Prevention Research), Stephen J. Gange(Johns Hopkins University), George Bailey(Oregon State University), Lisa P. Jacobson(Johns Hopkins University)
Cited by 303
Related Papers
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Consistent Viral Evolutionary Changes Associated with the Progression of Human Immunodeficiency Virus Type 1 Infection
|Journal of Virology|1999|956
SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity
|Nature Genetics|2001|734
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
|The Lancet|1992|731